New 13D21
New 13G69
Stated intents0
The week of 2026-06-22, 21 holders filed a new Schedule 13D and 69 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-06-24 | Made in USA Inc. | Tax Credits International Inc | 46.9% | SCHEDULE 13D |
| 2026-06-22 | XCF Global, Inc. | EEME Energy SPV I, LLC | 36.2% | SCHEDULE 13D |
| 2026-06-26 | RTB Digital, Inc. | Comer James Lamar Walton | 31.7% | SCHEDULE 13D |
| 2026-06-26 | New England Realty Associates Limited Partnership | Brown Jameson Pruitt | 31.5% | SCHEDULE 13D |
| 2026-06-24 | Lotus Technology Inc. | Etika Automotive Sdn Bhd | 27.8% | SCHEDULE 13D |
| 2026-06-25 | Office Properties Income Trust | Helix Partners Management LP | 25.3% | SCHEDULE 13D |
| 2026-06-25 | Office Properties Income Trust | Redwood Capital Management, LLC | 19.7% | SCHEDULE 13D |
| 2026-06-23 | EquipmentShare.com Inc | Jabbok Schlacks | 14.9% | SCHEDULE 13D |
| 2026-06-22 | Aditxt, Inc. | Takeover Time 2026 LLC | 10.9% | SCHEDULE 13D |
| 2026-06-26 | Cartesian Growth Corp III | WAVE Factorial Energy I, LLC | 10.7% | SCHEDULE 13D |
| 2026-06-24 | Azitra, Inc. | Salva Francisco D. | 9.99% | SCHEDULE 13D |
| 2026-06-25 | Allot Ltd. | Philotimo Fund, LP | 9.8% | SCHEDULE 13D |
| 2026-06-23 | Arax Holdings Corp. | Victor Vega | 9.7% | SCHEDULE 13D |
| 2026-06-25 | Kardigan, Inc. | Perceptive Advisors LLC | 8.9% | SCHEDULE 13D |
| 2026-06-23 | FS KKR Capital Corp. | KKR Alternative Assets L.P. | 7.8% | SCHEDULE 13D |
| 2026-06-22 | SEACOR Marine Holdings Inc. | Chernett Jorey | 7.19% | SCHEDULE 13D |
| 2026-06-22 | Health Catalyst, Inc. | Palogic Value Management, LP | 6.7% | SCHEDULE 13D |
| 2026-06-24 | Centessa Pharmaceuticals plc | Farallon Capital Management, L.L.C. | 6.1% | SCHEDULE 13D |
| 2026-06-23 | Equus Total Return, Inc. | Howard Todd Horberg | 5.61% | SCHEDULE 13D |
| 2026-06-24 | Aligos Therapeutics, Inc. | Lawrence M. Blatt | 5.6% | SCHEDULE 13D |
| 2026-06-23 | La Rosa Holdings Corp. | Benaim Eric | 5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-06-22 | Quantinuum Inc. | Ilyas Khan | 72% | SCHEDULE 13G |
| 2026-06-22 | Earth Science Tech, Inc. | Giorgio R. Saumat | 42.94% | SCHEDULE 13G |
| 2026-06-25 | Mountain Crest Acquisition 6 Corp. | Mountain Crest Holdings 6 LLC | 29.98% | SCHEDULE 13G |
| 2026-06-23 | Lakewood-Amedex Biotherapeutics Inc. | HPW Investments Holding Ltd. | 24.04% | SCHEDULE 13G |
| 2026-06-23 | WeShop Holdings Ltd | John B. Garner | 21.48% | SCHEDULE 13G |
| 2026-06-26 | Aditxt, Inc. | Wojcik Jerzy Stanislaw | 19.6% | SCHEDULE 13G |
| 2026-06-22 | BOXABL Inc. (formerly FG Merger II Corp.) | Atsion Asset Management LLC | 14.9% | SCHEDULE 13G |
| 2026-06-22 | Nyxoah SA | Orin Hirschman | 14.5% | SCHEDULE 13G |
| 2026-06-22 | Mammoth Energy Services, Inc. | Charles E. Davidson | 13.43% | SCHEDULE 13G |
| 2026-06-23 | Aditxt, Inc. | Tai Wey Ann | 12.3% | SCHEDULE 13G |
| 2026-06-22 | Aptevo Therapeutics Inc. | Niowave, Inc. | 12.2% | SCHEDULE 13G |
| 2026-06-23 | WeShop Holdings Ltd | Paul Teasdale | 11.86% | SCHEDULE 13G |
| 2026-06-26 | Quantum eMotion Corp. | Capital Ventures International | 11% | SCHEDULE 13G |
| 2026-06-26 | Teamshares Inc | VK Services, LLC | 10.4% | SCHEDULE 13G |
| 2026-06-23 | Tianci International, Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2026-06-23 | Faeth Therapeutics, Inc. | S2G Investments, LLC | 9.99% | SCHEDULE 13G |
| 2026-06-24 | Tianci International, Inc. | S.H.N. Financial Investments Ltd. | 9.99% | SCHEDULE 13G |
| 2026-06-24 | Adial Pharmaceuticals, Inc. | Coastlands Capital LP | 9.98% | SCHEDULE 13G |
| 2026-06-22 | Azitra, Inc. | Stonepine Capital Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-06-22 | Aditxt, Inc. | Hester Jonathan Edward | 9.9% | SCHEDULE 13G |
| 2026-06-23 | Data I/O Corp | Lytton Laurence W | 9.9% | SCHEDULE 13G |
| 2026-06-22 | DevvStream Corp. | Helena Global Investment Opportunities 1 Ltd. | 9.82% | SCHEDULE 13G |
| 2026-06-25 | Azitra, Inc. | Dauntless Investment Group, LLC | 9.6% | SCHEDULE 13G |
| 2026-06-25 | Fulcrum Therapeutics, Inc. | EcoR1 Capital, LLC | 9% | SCHEDULE 13G |
| 2026-06-25 | Fulcrum Therapeutics, Inc. | EcoR1 Capital, LLC | 9% | SCHEDULE 13G |
| 2026-06-26 | Maxeon Solar Technologies, Ltd. | Whitebox Advisors LLC | 8.5% | SCHEDULE 13G |
| 2026-06-26 | Teamshares Inc | QED Growth Fund, L.P. | 8.3% | SCHEDULE 13G |
| 2026-06-24 | HeartSciences Inc. | Fields Ephraim G | 8.1% | SCHEDULE 13G |
| 2026-06-23 | Faeth Therapeutics, Inc. | Suvretta Capital Management, LLC | 7.8% | SCHEDULE 13G |
| 2026-06-23 | WeShop Holdings Ltd | John Robert Foley | 7.62% | SCHEDULE 13G |
| 2026-06-23 | Sleep Number Corp | AQR Capital Management, LLC | 7.61% | SCHEDULE 13G |
| 2026-06-26 | Zepp Health Corp | Morgan Stanley | 7.5% | SCHEDULE 13G |
| 2026-06-26 | Volato Group, Inc. | Catheter Precision, Inc. | 7.5% | SCHEDULE 13G |
| 2026-06-25 | Passage BIO, Inc. | Baselake Partners, LP | 7.3% | SCHEDULE 13G |
| 2026-06-22 | Poet Technologies Inc. | Jane Street Group, LLC | 6.8% | SCHEDULE 13G |
| 2026-06-25 | Ryde Group Ltd | GreenTech Investment Alliance Ltd. | 6.62% | SCHEDULE 13G |
| 2026-06-23 | Yorkville International Capital Corp. | Tenor Capital Management Company, L.P. | 6.5% | SCHEDULE 13G |
| 2026-06-26 | Wilco 63 Corp. | MMCAP International Inc. SPC | 6.5% | SCHEDULE 13G |
| 2026-06-23 | Insight Enterprises Inc | Fiduciary Management Inc | 6.2% | SCHEDULE 13G |
| 2026-06-24 | Cantor Equity Partners VII, Inc. | RP Investment Advisors LP | 6.2% | SCHEDULE 13G |
| 2026-06-25 | SRX Global Inc. | Les Filles, LLC | 6.2% | SCHEDULE 13G |
| 2026-06-23 | Sleep Number Corp | Jane Street Group, LLC | 6.1% | SCHEDULE 13G |
| 2026-06-24 | HCM III Acquisition Corp | RP Investment Advisors LP | 6.1% | SCHEDULE 13G |
| 2026-06-25 | AstroNova, Inc. | Glazer Capital, LLC | 5.81% | SCHEDULE 13G |
| 2026-06-23 | Omada Health, Inc. | The Cigna Group | 5.8% | SCHEDULE 13G |
| 2026-06-23 | Pasithea Therapeutics Corp. | Stonepine Capital Management, LLC | 5.8% | SCHEDULE 13G |
| 2026-06-24 | DXC Technology Co | Millennium Management LLC | 5.7% | SCHEDULE 13G |
| 2026-06-25 | Soligenix, Inc. | Michael Liu | 5.7% | SCHEDULE 13G |
| 2026-06-23 | Huron Consulting Group Inc. | Fiduciary Management Inc | 5.5% | SCHEDULE 13G |
| 2026-06-23 | Lakefront Biotherapeutics NV | Madison Avenue International LP | 5.5% | SCHEDULE 13G |
| 2026-06-23 | Aditxt, Inc. | Burciu Emil Cristian | 5.5% | SCHEDULE 13G |
| 2026-06-26 | CervoMed Inc. | CVI Investments, Inc. | 5.5% | SCHEDULE 13G |
| 2026-06-22 | Cantor Equity Partners VII, Inc. | MMCAP International Inc. SPC | 5.3% | SCHEDULE 13G |
| 2026-06-24 | Ascent Solar Technologies, Inc. | Jane Street Group, LLC | 5.3% | SCHEDULE 13G |
| 2026-06-23 | Jiuzi Holdings, Inc. | Jane Street Group, LLC | 5.2% | SCHEDULE 13G |
| 2026-06-24 | MBX Biosciences, Inc. | Paradigm BioCapital Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-06-25 | AIB Data Centers Inc. | Point72 Asset Management, L.P. | 5.2% | SCHEDULE 13G |
| 2026-06-25 | Unifi, Inc. | Peter J Abrahamson | 5.2% | SCHEDULE 13G |
| 2026-06-25 | Wilco 63 Corp. | Sculptor Capital LP | 5.19% | SCHEDULE 13G |
| 2026-06-22 | Gpgi Inc | Locust Wood Capital Advisers, LLC | 5.1% | SCHEDULE 13G |
| 2026-06-22 | Cracker Barrel Old Country Store, Inc. | D. E. Shaw & Co., L.P. | 5.1% | SCHEDULE 13G |
| 2026-06-24 | Galaxy Digital Inc | Jane Street Group, LLC | 5.1% | SCHEDULE 13G |
| 2026-06-25 | Leslie's, Inc. | Jane Street Group, LLC | 5.1% | SCHEDULE 13G |
| 2026-06-26 | Viridian Therapeutics, Inc. | Paradigm BioCapital Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-06-26 | Lenz Therapeutics Inc | Millennium Management LLC | 5.1% | SCHEDULE 13G |
| 2026-06-26 | Teamshares Inc | Spark Growth Management Partners III, LLC | 5.1% | SCHEDULE 13G |
| 2026-06-26 | Drugs Made In America Acquisition Corp. | Feis Equities LLC | 5.08% | SCHEDULE 13G |
| 2026-06-23 | Talen Energy Corp | ECP ControlCo, LLC | 5.01% | SCHEDULE 13G |
| 2026-06-22 | Teladoc Health, Inc. | Voss Capital, LP | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)90 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.